RepliCel Life Sciences Inc (TSXV:RP)
RepliCel is a regenerative medicine company developing autologous cell therapies that address diseases caused by a deficit of healthy cells required for normal healing and function.
China Diagnostics Medical of Beijing raised $292 million in a fundraising led by Legend Capital, a China private equity firm, which contributed $100 million of the total. Founded in 1999, CDM designs and develops diagnostic testing reagents, including biochemical, chemiluminescence and radioactive reagents. China Renaissance’s healthcare fund co-led the round. CDM claims it prices its HIV reagents at about one-third the price of comparable HIV reagents from multinational biopharmas.
Source: China Biotoday
